Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Lung Neoplasms × Bupivacaine × Clear all

Phase

Status

Completed 4 Unknown 2 Terminated 1 Recruiting 1 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Upper Abdominal Cancer Surgery 1 Lung Neoplasms 1 Disease 1 Colorectal Neoplasms 1 Agnosia 1

Interventions

Drug Therapy 9 Specimen Handling 8 Magnetic Resonance Spectroscopy 7 osimertinib 6 Carboplatin 6 atezolizumab 4 Pemetrexed 4 pembrolizumab 3 Tomography, X-Ray Computed 3 Injections 3 durvalumab 2 cemiplimab 2 anlotinib 2 Surgical Procedures, Operative 2 Standard of Care 2 Radiosurgery 2 Magnetic Resonance Imaging 2 Immunotherapy 2 Etoposide 2 Educational Status 2 Cisplatin 2 Blood Specimen Collection 2 Biopsy 2 Bevacizumab 2 Anesthesia 2 Acupuncture Therapy 2 130-nm albumin-bound paclitaxel 2 tucatinib 1 tremelimumab 1 tislelizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07254650 2025-11-28

CALMS-1

University of Texas Southwestern Medical Center

Phase NA Not yet recruiting

Agnosia, Disease, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡